定制的 HER2 ECD mRNA-LNP 疫苗增强 CD8(+) T 细胞介导的抗肿瘤免疫以抑制 HER2 阳性肿瘤
Tailored HER2 ECD mRNA-LNP vaccines boost CD8(+) T cell-mediated antitumor immunity for HER2-positive tumor suppression.
88.8分
★★★★★
站内排序·非疗效
ALL SOURCES
Tailored HER2 ECD mRNA-LNP vaccines boost CD8(+) T cell-mediated antitumor immunity for HER2-positive tumor suppression.
In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy.
Chimeric Antigen Receptor-Engineered Cell Membrane-Coated Nanoparticles Promote Dual-Targeted mRNA-Based Cancer Gene Therapy.
Advancements in CAR-T Cell Therapy for Ovarian Cancer: Current Strategies and Future Directions.
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。